A pounds 17m out-of-court settlement ended one of the largest personal injury actions to be heard in the English courts. More than 400 patients claimed they suffered back pain after a dye, Myodil, was injected into their spines for a diagnostic back scan. They alleged that the manufacturers, Glaxo Laboratories, failed properly to research, test and develop the dye, which was withdrawn in 1987.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments